Table 2.
TST and QFT-Plus results based on nutritional status, chemotherapy history, therapy duration, and patient groups.
| Variables assessed | TST (n = 71) | QFT-Plus | |||||||
|---|---|---|---|---|---|---|---|---|---|
| + | − | Total (n) | p value | + | Indeterminate | − | Total | p value | |
| Nutritional status | |||||||||
| Normal | 3 | 46 | 49 | 0.72 | 7 | 1 | 41 | 49 | 0.76 |
| Moderately malnourished | 0 | 12 | 12 | 1 | 0 | 11 | 12 | ||
| Severely malnourished | 1 | 9 | 10 | 3 | 0 | 7 | 10 | ||
| Therapy | |||||||||
| Chemotherapy | 4 | 36 | 40 | 0.19 | 6 | 1 | 33 | 40 | 0.11 |
| Chemotherapy+steroid | 0 | 29 | 29 | 5 | 0 | 24 | 29 | ||
| Steroid | 0 | 2 | 2 | 0 | 0 | 2 | 2 | ||
| Duration of therapy | |||||||||
| ≤3 months | 2 | 27 | 29 | 1.0 | 5 | 0 | 24 | 29 | 0.67 |
| >3 months | 2 | 40 | 42 | 6 | 1 | 35 | 42 | ||
| Patient classification | |||||||||
| Hematological | 3 | 37 | 40 | 0.45 | 6 | 1 | 33 | 40 | 0.26 |
| Nephrological | 0 | 19 | 19 | 1 | 0 | 18 | 19 | ||
| Immunological | 1 | 11 | 12 | 4 | 0 | 8 | 12 | ||
| BCG status | |||||||||
| Positive | 4 | 63 | 67 | 1.0 | 11 | 1 | 55 | 67 | 0.65 |
| Negative | 0 | 4 | 4 | 0 | 0 | 4 | 4 | ||
TST: tuberculin skin test; QFT-Plus: QuantiFERON Gold Plus.